Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
-
- Michael J. Rybak
- Anti-Infective Research Laboratory, Department of Pharmacy Practice, College of Pharmacy & Health Sciences, and Detroit Receiving Hospital & University Health Center, Detroit, Michigan
-
- Ben M. Lomaestro
- Albany Medical Center, Albany, New York
-
- John C. Rotscahfer
- Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis
-
- Robert C. Moellering
- Shields Warren-Mallinckrodt Medical Research, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
-
- Willam A. Craig
- University of Wisconsin School of Medicine and Public Health, Madison
-
- Marianne Billeter
- Oshsner Medical Centers and Department of Infectious Diseases, Oschsner Health System, New Orleans, Louisiana
-
- Joseph R. Dalovisio
- Department of Infectious Diseases, Oschsner Health System, New Orleans, Louisiana
-
- Donald P. Levine
- Detroit Receiving Hospital & University Health Center, Detroit, Michigan
Description
<jats:title>Abstract</jats:title> <jats:p>Practice guidelines for therapeutic monitoring of vancomycin treatment for Staphylococcus aureus infection in adult patients were reviewed by an expert panel of the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. A literature review of existing evidence regarding vancomycin dosing and monitoring of serum concentrations, in addition to patient outcomes combined with expert opinion regarding the drug's pharmacokinetic, pharmacodynamic, and safety record, resulted in new recommendations for targeting and adjustment of vancomycin therapy.</jats:p>
Journal
-
- Clinical Infectious Diseases
-
Clinical Infectious Diseases 49 (3), 325-327, 2009-08-01
Oxford University Press (OUP)
- Tweet
Details 詳細情報について
-
- CRID
- 1361418521316343680
-
- DOI
- 10.1086/600877
-
- ISSN
- 15376591
- 10584838
-
- Data Source
-
- Crossref